文献速递腹部技术与安全CT

基于CT的整肝肿瘤负荷几何与影像组学分析对转移性结直肠癌患者生存预测的相关性

The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer.
PubMed 文献 · Eur Radiol · 2020-08-27

这项回顾性研究纳入103例结直肠癌肝转移患者,基于基线增强CT自动分割整肝肿瘤负荷,比较几何转移分布模型、Aerts影像组学先验模型、肿瘤负荷评分、整肝肿瘤负荷体积及临床模型对1年生存的预测效能。统计设置下肿瘤负荷评分 discriminative 表现最佳(AUC=0.70),机器学习预测未见患者时几何转移分布模型(AUC=0.73)和Aerts影像组学先验模型(AUC=0.76)数值上高于肿瘤负荷评分(AUC=0.68)等。作者认为基于影像的几何转移分布模型可能成为肿瘤负荷评分概念向更精细机器学习扩展的第一步。

要点

  • 统计设置下肿瘤负荷评分对1年生存的 discriminative 表现最佳,AUC=0.70(CI:[0.56, 0.90])。
  • 机器学习预测未见患者时,整肝肿瘤负荷的几何转移分布模型AUC=0.73(CI:[0.60, 0.84])。
  • 机器学习预测未见患者时,Aerts影像组学先验模型AUC=0.76(CI:[0.65, 0.86]),数值上高于肿瘤负荷评分AUC=0.68(CI:[0.54, 0.79])。

核心结论

  • 基于影像的几何转移分布模型可能成为肿瘤负荷评分概念向更精细机器学习扩展的第一步,用于转移性结直肠癌患者风险分层,且不易受影像组学技术变异的影响。

研究设计与样本

  • 回顾性研究,纳入103例结直肠癌肝转移患者(平均年龄61.0±11.2岁)。
  • 基于基线增强CT图像对整肝肿瘤负荷进行自动分割。
  • 采用已建立的生物标志物及标准影像组学模型构建方法推导3个预后模型。
  • 评估几何转移分布模型、整肝肿瘤负荷的Aerts影像组学先验模型、肿瘤负荷评分及整肝肿瘤负荷体积单独的性能。
  • 所有模型在统计和预测机器学习两种设置下以AUC进行分析。

诊断标准与关键数值

  • 统计设置下,肿瘤负荷评分区分1年生存的AUC=0.70(CI:[0.56, 0.90])。
  • 机器学习预测未见患者时,整肝肿瘤负荷的几何转移分布模型AUC=0.73(CI:[0.60, 0.84])。
  • 机器学习预测未见患者时,Aerts影像组学先验模型应用于整肝肿瘤负荷的AUC=0.76(CI:[0.65, 0.86])。
  • 机器学习预测未见患者时,肿瘤负荷评分AUC=0.68(CI:[0.54, 0.79])、影像组学AUC=0.65(CI:[0.55, 0.78])、整肝肿瘤负荷体积单独AUC=0.53(CI:[0.40, 0.66])、临床模型AUC=0.56(CI:[0.43, 0.67])。

临床应用与阅片要点

  • CT-based geometric distribution and radiomics analysis of whole liver tumor burden in metastatic colorectal cancer patients yield prognostic information.
  • Differences in survival are possibly attributable to the spatial distribution of metastatic lesions and the geometric metastatic spread analysis of all liver metastases may serve as robust imaging biomarker invariant to technical variation.
  • Imaging-based prediction models outperform clinical models for 1-year survival prediction in metastatic colorectal cancer patients with liver metastases.

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the prediction of 1-year survival (1-YS) in patients with metastatic colorectal cancer with use of a systematic comparative analysis of quantitative imaging biomarkers (QIBs) based on the geometric and radiomics analysis of whole liver tumor burden (WLTB) in comparison to predictions based on the tumor burden score (TBS), WLTB volume alone, and a clinical model.

METHODS: A total of 103 patients (mean age: 61.0 ± 11.2 years) with colorectal liver metastases were analyzed in this retrospective study. Automatic segmentations of WLTB from baseline contrast-enhanced CT images were used. Established biomarkers as well as a standard radiomics model building were used to derive 3 prognostic models. The benefits of a geometric metastatic spread (GMS) model, the Aerts radiomics prior model of the WLTB, and the performance of TBS and WLTB volume alone were assessed. All models were analyzed in both statistical and predictive machine learning settings in terms of AUC.

RESULTS: TBS showed the best discriminative performance in a statistical setting to discriminate 1-YS (AUC = 0.70, CI: [0.56, 0.90]). For the machine learning-based prediction for unseen patients, both a model of the GMS of WLTB (0.73, CI: [0.60, 0.84]) and the Aerts radiomics prior model (0.76, CI: [0.65, 0.86]) applied on the WLTB showed a numerically higher predictive performance than TBS (0.68, CI: [0.54, 0.79]), radiomics (0.65, CI: [0.55, 0.78]), WLTB volume alone (0.53, CI: [0.40. 0.66]), or the clinical model (0.56, CI: [0.43, 0.67]).

CONCLUSIONS: The imaging-based GMS model may be a first step towards a more fine-grained machine learning extension of the TBS concept for risk stratification in mCRC patients without the vulnerability to technical variance of radiomics.

KEY POINTS: • CT-based geometric distribution and radiomics analysis of whole liver tumor burden in metastatic colorectal cancer patients yield prognostic information. • Differences in survival are possibly attributable to the spatial distribution of metastatic lesions and the geometric metastatic spread analysis of all liver metastases may serve as robust imaging biomarker invariant to technical variation. • Imaging-based prediction models outperform clinical models for 1-year survival prediction in metastatic colorectal cancer patients with liver metastases.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Mühlberg A, Holch JW, Heinemann V, et al. The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer. Eur Radiol. 2020. PMID: 32851450. doi:10.1007/s00330-020-07192-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。